November 2017: diagnosed with Stage IV, High-Risk Neuroblastoma;
Nov 2017-April 2019: completed standard treatment protocol / no evidence of disease;
April 2019-April 2021: enrolled in/completed DFMO clinical trial;
April 2022: RELAPSE;
April 2022-June 2023: completed relapse treatment protocol / no evidence of disease (again);
June 2023-June 2024: enrolled in “compassionate use” high-dose DFMO clinical trial;
June 2024: RELAPSE #2
Tuesday, March 6, 2018
Happy Birthday, Andrew!
Happy 10th Birthday, Andrew!
We're so proud of how you're handling your sister's diagnosis; she's so lucky to have such a protective and sweet brother!
Unconditional love forever and ever,
Mommy and Daddy
Happy Birthday Andrew. ��
ReplyDelete